Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my guiding principle in this crisis is simple: You cannot manage a balance sheet if you destroy your soul, and you cannot protect shareholders by killing patients. Delaying disclosure of a fatal side effect to protect a stock price is not only a profound ethical failure; it is corporate suicide.Read the full answer
This is a critical governance and safety scenario. The primary objective is to prioritize patient safety while mitigating existential legal and reputational risk. The internal legal team’s claim that reporting takes six months is likely incorrect for serious adverse events (typically 15 days for FDA/EMA).Read the full answer